Dr. J. Edie De Niro Graduated from Williams College summa cum laude and Phi Beta Kappa in 1999. She attended medical school at the University of California, San Francisco, graduating in 2009. She then went on to complete her ophthalmology residency at California Pacific Medical Center in 2013 and glaucoma fellowship at the University of California, Davis in 2015. She was associate program director of the ophthalmology residency program at California Pacific Medical Center from 2015 through 2018 and continues to teach residents at Highland Hospital and California Pacific Medical Center. She is a diplomate of the American Board of Ophthalmology and a member of the American Academy of Ophthalmology.
Dr. De Niro is currently accepting new patients for glaucoma consultation and surgery as well as for comprehensive ophthalmology. In addition to glaucoma surgery, she specializes in cataract surgery, including Laser Assisted Cataract Surgery with the femtosecond laser, multifocal lenses and astigmatism-correcting lenses.
Please contact us directly with any questions, comments, or scheduling inquiries you may have.
Please note that our office hours and phone system officially begins at 8:30am during business hours. Our doors open as early as 7:30am to accommodate patients with special needs for early morning appointments.
491 30th Street Suite 201 Oakland, CA 94609 US
08:30 am – 05:00 pm
The MacArthur BART station, on Telegraph Avenue, is about 17 minutes' walk north of our office. A free medical area shuttle service, operated by Alta Bates Summit Medical Center, offers a complimentary ride from MacArthur BART station to 3100 Telegraph Ave every 20 minutes. Our office is just across the street from the shuttle stop. Please click here for shuttle information.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.